Literature DB >> 19330946

Fluorescent dye labeled influenza virus mainly infects innate immune cells and activated lymphocytes and can be used in cell-mediated immune response assay.

Dongxu Xie1.   

Abstract

Early results have recognized that influenza virus infects the innate and adaptive immune cells. The data presented in this paper demonstrated that influenza virus labeled with fluorescent dye not only retained the ability to infect and replicate in host cells, but also stimulated a similar human immune response as did unlabeled virus. Influenza virus largely infected the innate and activated adaptive immune cells. Influenza B type virus was different from that of A type virus. B type virus was able to infect the immature lymphocytes, but in lower amounts when compared to activated lymphocytes. Protection from influenza is tightly associated with cellular immunity. Traditional methods of cellular immunity assay had limitations to imitate the natural human cell-mediated responses to influenza virus. Labeled viruses could be used in the assay of virus-specific cytotoxicity, which might reflect the natural process more closely. Furthermore, human immune cells activated by one influenza subtype virus could kill the cells infected by other subtype virus. These results implied the human immune cells could directly handle and remove free virus using similar mechanism that was used to remove virus-infected nonimmune cells, which might help to simplify the design and production of influenza vaccine, thereby reduce the cost.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19330946      PMCID: PMC2888934          DOI: 10.1016/j.jim.2009.01.008

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  21 in total

1.  Use of overlapping peptide mixtures as antigens for cytokine flow cytometry.

Authors:  H T Maecker; H S Dunn; M A Suni; E Khatamzas; C J Pitcher; T Bunde; N Persaud; W Trigona; T M Fu; E Sinclair; B M Bredt; J M McCune; V C Maino; F Kern; L J Picker
Journal:  J Immunol Methods       Date:  2001-09-01       Impact factor: 2.303

2.  Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates.

Authors:  Luzheng Liu; Ann Chahroudi; Guido Silvestri; Mary E Wernett; William J Kaiser; Jeffrey T Safrit; Akira Komoriya; John D Altman; Beverly Z Packard; Mark B Feinberg
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

3.  A systematic comparison of methods to measure HIV-1 specific CD8 T cells.

Authors:  Y Sun; E Iglesias; A Samri; G Kamkamidze; T Decoville; G Carcelain; B Autran
Journal:  J Immunol Methods       Date:  2003-01-15       Impact factor: 2.303

Review 4.  Will we be able to 'spot' an effective HIV-1 vaccine?

Authors:  Otto O Yang
Journal:  Trends Immunol       Date:  2003-02       Impact factor: 16.687

5.  Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation.

Authors:  Michael R Betts; Jason M Brenchley; David A Price; Stephen C De Rosa; Daniel C Douek; Mario Roederer; Richard A Koup
Journal:  J Immunol Methods       Date:  2003-10-01       Impact factor: 2.303

6.  Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide.

Authors:  A E Lee-MacAry; E L Ross; D Davies; R Laylor; J Honeychurch; M J Glennie; D Snary; R W Wilkinson
Journal:  J Immunol Methods       Date:  2001-06-01       Impact factor: 2.303

7.  The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals.

Authors:  M M Addo; M Altfeld; E S Rosenberg; R L Eldridge; M N Philips; K Habeeb; A Khatri; C Brander; G K Robbins; G P Mazzara; P J Goulder; B D Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

8.  A novel cytotoxicity assay to evaluate antigen-specific CTL responses using a colorimetric substrate for Granzyme B.

Authors:  Catherine Ewen; Kevin P Kane; Irene Shostak; Philip J Griebel; Edward M Bertram; Tania H Watts; R C Bleackley; Janet E McElhaney
Journal:  J Immunol Methods       Date:  2003-05-01       Impact factor: 2.303

9.  Detection of virus-specific T cells and CD8+ T-cell epitopes by acquisition of peptide-HLA-GFP complexes: analysis of T-cell phenotype and function in chronic viral infections.

Authors:  Utano Tomaru; Yoshihisa Yamano; Masahiro Nagai; Dragan Maric; Previn T P Kaumaya; William Biddison; Steven Jacobson
Journal:  Nat Med       Date:  2003-03-24       Impact factor: 53.440

10.  Ex vivo identification, isolation and analysis of tumor-cytolytic T cells.

Authors:  Valerie Rubio; Tor B Stuge; Naileshni Singh; Michael R Betts; Jeffrey S Weber; Mario Roederer; Peter P Lee
Journal:  Nat Med       Date:  2003-10-05       Impact factor: 53.440

View more
  3 in total

1.  Successive influenza virus infection and Streptococcus pneumoniae stimulation alter human dendritic cell function.

Authors:  Yuet Wu; Huawei Mao; Man-To Ling; Kin-Hung Chow; Pak-Leung Ho; Wenwei Tu; Yu-Lung Lau
Journal:  BMC Infect Dis       Date:  2011-07-20       Impact factor: 3.090

Review 2.  The β-Lactamase Assay: Harnessing a FRET Biosensor to Analyse Viral Fusion Mechanisms.

Authors:  Daniel M Jones; Sergi Padilla-Parra
Journal:  Sensors (Basel)       Date:  2016-06-23       Impact factor: 3.576

3.  Influenza Virus Infects and Depletes Activated Adaptive Immune Responders.

Authors:  Caitlin D Bohannon; Zachary Ende; Weiping Cao; Wadzanai P Mboko; Priya Ranjan; Amrita Kumar; Margarita Mishina; Samuel Amoah; Shivaprakash Gangappa; Suresh K Mittal; Jonathan F Lovell; Adolfo García-Sastre; Blaine A Pfeifer; Bruce A Davidson; Paul Knight; Suryaprakash Sambhara
Journal:  Adv Sci (Weinh)       Date:  2021-06-30       Impact factor: 16.806

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.